A 74-year-old male with chronic cervicalgia and OSA developed tinnitus and diplopia in 2021. Exam showed left gaze palsy and normal brain MRI. Patient was diagnosed with MRI-negative stroke, improved for three months, then developed ataxia, vertigo, bilateral hypoacusis, and falls requiring readmission. CSF showed elevated protein without pleocytosis and negative infectious, autoimmune, cytologic studies. MRI showed T2 hyperintensities in the brainstem, cerebellar hemispheres, thalami, subcortical white matter. Brain biopsy demonstrated perivascular lymphohistiocytic inflammation without vasculitis, granulomas, or neoplasm, consistent with CLIPPERS. Patient improved with IV steroids, prednisone taper, and methotrexate. After a 3-year stable period, patient developed dizziness, tinnitus, imbalance, cognitive impairment, and phosphenes. MRI showed new enhancing pontine, brainstem, and cerebellar lesions with right posterior corpus callosum infarcts. Vasculitis evaluation and GFAP antibodies were negative. Patient was treated with prednisone and switched to mycophenolate with partial improvement; however, symptoms worsened during tapering and repeat MRI showed progressive supra and infratentorial enhancing lesions involving bilateral basal ganglia, corpus callosum, parieto-occipital, and sensorimotor cortices, consistent with SLIPPERS. He improved after IV steroids and rituximab.